Clinical Trial Update: Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating L-Carnitine supplementation for respiratory distress syndrome in premature birth was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Birth
• Respiratory Distress Syndrome

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Assiut University | Conditions: Premature Birth | Phase 4 | Status: WITHDRAWN